These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1485 related items for PubMed ID: 16401843

  • 1. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW.
    Neurology; 2006 Jan 10; 66(1):41-8. PubMed ID: 16401843
    [Abstract] [Full Text] [Related]

  • 2. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT.
    Acta Neuropathol; 2007 Nov 10; 114(5):471-9. PubMed ID: 17721707
    [Abstract] [Full Text] [Related]

  • 3. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M, Negoro K, Mori H.
    Rinsho Shinkeigaku; 2004 Nov 10; 44(11):982-5. PubMed ID: 15651349
    [Abstract] [Full Text] [Related]

  • 4. The evolution and pathology of frontotemporal dementia.
    Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG.
    Brain; 2005 Sep 10; 128(Pt 9):1996-2005. PubMed ID: 16033782
    [Abstract] [Full Text] [Related]

  • 5. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
    Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW.
    Arch Neurol; 2006 Apr 10; 63(4):506-12. PubMed ID: 16606762
    [Abstract] [Full Text] [Related]

  • 6. Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy.
    Kertesz A.
    Neurologist; 2003 Nov 10; 9(6):311-7. PubMed ID: 14629785
    [Abstract] [Full Text] [Related]

  • 7. Frontotemporal lobar degeneration: clinical and pathological relationships.
    Snowden J, Neary D, Mann D.
    Acta Neuropathol; 2007 Jul 10; 114(1):31-8. PubMed ID: 17569065
    [Abstract] [Full Text] [Related]

  • 8. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND.
    Josephs KA, Knopman DS, Whitwell JL, Boeve BF, Parisi JE, Petersen RC, Dickson DW.
    Neurology; 2005 Aug 23; 65(4):645-7. PubMed ID: 16116138
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
    Lladó A, Sánchez-Valle R, Rey MJ, Ezquerra M, Tolosa E, Ferrer I, Molinuevo JL, Catalan collaborative Study Group for FTLD.
    J Neurol; 2008 Apr 23; 255(4):488-94. PubMed ID: 18357425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Frontotemporal dementia.
    Graff-Radford NR, Woodruff BK.
    Semin Neurol; 2007 Feb 23; 27(1):48-57. PubMed ID: 17226741
    [Abstract] [Full Text] [Related]

  • 12. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sha S, Hou C, Viskontas IV, Miller BL.
    Nat Clin Pract Neurol; 2006 Dec 23; 2(12):658-65. PubMed ID: 17117169
    [Abstract] [Full Text] [Related]

  • 13. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.
    Lipton AM, White CL, Bigio EH.
    Acta Neuropathol; 2004 Nov 23; 108(5):379-85. PubMed ID: 15351890
    [Abstract] [Full Text] [Related]

  • 14. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ, Nishihira Y, Kuroda S, Toyoshima Y, Ishihara T, Shinozaki M, Miyashita A, Piao YS, Tan CF, Tani T, Koike R, Iwanaga K, Tsujihata M, Onodera O, Kuwano R, Nishizawa M, Kakita A, Ikeuchi T, Takahashi H.
    Acta Neuropathol; 2010 Jul 23; 120(1):21-32. PubMed ID: 20140439
    [Abstract] [Full Text] [Related]

  • 15. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration.
    Schofield EC, Caine D, Kril JJ, Cordato NJ, Halliday GM.
    Mov Disord; 2005 Jan 23; 20(1):34-9. PubMed ID: 15390131
    [Abstract] [Full Text] [Related]

  • 16. The diagnosis and course of frontotemporal dementia.
    Kertesz A, Blair M, McMonagle P, Munoz DG.
    Alzheimer Dis Assoc Disord; 2007 Jan 23; 21(2):155-63. PubMed ID: 17545742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy.
    Tuite PJ, Clark HB, Bergeron C, Bower M, St George-Hyslop P, Mateva V, Anderson J, Knopman DS.
    Arch Neurol; 2005 Sep 23; 62(9):1453-7. PubMed ID: 16157754
    [Abstract] [Full Text] [Related]

  • 20. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B, Malinverno M, Gardoni F, Alberici A, Parnetti L, Premi E, Bonuccelli U, Grassi M, Perani D, Calabresi P, Di Luca M, Padovani A.
    Neurology; 2008 Nov 25; 71(22):1796-803. PubMed ID: 18971445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.